Lumin Health Newsroom

A clinical-operator perspective on Spravato, psychedelic care, treatment-resistant depression, and the future of interventional psychiatry.

We respond to media inquiries within 24 hours.

Email media team →

Key facts about Lumin Health

A clinical-operator perspective for reporters covering Spravato, treatment-resistant depression, and psychedelic medicine.

Five-site in-network operator

Lumin Health operates five interventional psychiatry locations — Newton, Cambridge, Woburn, Brookline (MA) and Bethesda (MD) — fully in-network with Aetna, BCBS, Cigna, UnitedHealthcare, Optum, Medicare, and 8+ other major payers.

View locations →

Hundreds of patients each month

Across the network, Lumin Health treats hundreds of patients each month receiving Spravato (esketamine), IM ketamine, oral ketamine, and integrative psychotherapy for treatment-resistant depression and related conditions.

Patient experience →

Harvard-trained medical leadership

Four of five Lumin Health medical directors are Harvard Medical School faculty. Co-Founder and CMO Dr. Benjamin Yudkoff previously served as Medical Director of the Brigham and Women's Faulkner Hospital Interventional Psychiatry Service.

Meet the team →

On-the-record clinical experts

Five board-certified psychiatrists are available for media interviews on Spravato access, treatment-resistant depression, ketamine and esketamine clinical care, MDMA-assisted psychotherapy training, and the future of interventional psychiatry.

Email press team →

Original aggregate data

Quarterly Lumin Insights releases surface aggregate, de-identified data on Spravato access, payer approval rates, patient wait times, and care-pathway outcomes from real-world community practice. First release Q2 2026.

Lumin Insights →

24-hour media response

We respond to all media inquiries within 24 hours. For breaking news on Spravato, FDA action on psychedelics, or J&J earnings coverage, our experts can respond within 2 hours during business hours.

Email media team →

Hundreds of 5-star patient reviews

Lumin Health patients consistently rate their treatment experience 5 stars across Google and review platforms. Many describe Lumin Health as the first place they felt heard after years of treatment-resistant depression.

Patient reviews →

Meet our medical leadership

Five board-certified psychiatrists across Lumin Health's clinics, available for press interviews, expert quotes, and original-data exclusives.

Featured spokesperson

Benjamin Yudkoff, MD, MA

Co-Founder & Chief Medical Officer, Lumin Health

Instructor in Psychiatry · Harvard Medical School Board-certified psychiatrist

"Lumin Health is a clinical-operator voice on the in-network model that finally made Spravato accessible at scale. Our medical directors — Drs. Mosquera, Sathappan, Fletcher, Itani, and myself — are available for press interviews, expert quotes, and original-data exclusives."

Email media team → View full team

Also available for press: Dr. Matthew Mosquera (Regional Medical Director, double board-certified general + addiction psychiatry), Dr. Aakash Sathappan (Brookline; authored first informed consent guidelines for ketamine in adolescent TRD), Dr. SJ Fletcher (Woburn; MAPS-trained MDMA-assisted psychotherapy), Dr. Mona Itani (Newton; trauma-informed integrative psychiatry, IFS).

Areas of media expertise

Lumin Health spokespeople are available to comment on Spravato access, treatment-resistant depression, esketamine and ketamine clinical care, MDMA-assisted psychotherapy training, the FDA pathway for psychedelic medicine, insurance integration in psychiatry, and the mental-health workforce shortage.

Spravato access & insurance integration Treatment-resistant depression (TRD) Ketamine & esketamine clinical care MDMA-assisted psychotherapy Psilocybin & FDA pathway Adolescent psychiatric care Trauma-informed care & IFS Addiction psychiatry Mental health workforce shortage Treatment options in mental health for hard-to-beat cases

Email media team →

Five Lumin Health clinics across MA and MD

A friendly face at the Lumin Health front desk, greeting patients as they enter for their bespoke insurance-covered ketamine treatment and esketamine therapy with 5-star reviews and Harvard-trained doctors and physicians

Newton

10 Langley Road, Suite 200
Newton, MA 02459
Phone 617-741-5931

Learn more

Cambridge (Harvard Square)

50 Church Street, 3rd floor
Cambridge, MA 02138
Phone 781-734-6854

Learn more

Woburn

300 TradeCenter Drive, Suite 3400
Woburn, MA 01801
Phone 617-644-4045

Learn more

Brookline

1101 Beacon Street, Suite 4E
Brookline, MA 02446
Phone 617-925-9852

Learn more

Bethesda

4825 Bethesda Ave Suite 200
Bethesda, MD 20814
Phone 301-407-6235

Learn more

Press contact

For all media inquiries — interview requests, quote requests, story development, original-data exclusives, and quarterly Lumin Insights pre-publication access — email press@lumin.health. We respond within 24 hours.

Media contact

Alec Sherman

Head of Digital, Lumin Health

Email: press@lumin.health

For breaking news, contact Alec Sherman directly.

Email press team →